Bevacizimab

4 registered clinical trials studyying Bevacizimab — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatell NCT07500298	M.D. Anderson Cancer Center	Phase 1
Recruiting	Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma NCT07324824	Sun Yat-sen University	Phase 2
Completed	Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma NCT04143425	Ho Sung Kim	—
Completed	Chronic Inflammation, Plasma Proteins Signature, Survival Outcomes and Clinical Response, in Patients Receivin NCT07241403	Second Affiliated Hospital of Nanchang University	—